The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19
The Clinical Difference Between the Nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the Fatal Cases With Severe COVID-19
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Listed as NCT04403009, this observational or N/A phase trial focuses on Character of the Severe Patients and Coronavirus Disease 2019 and remains completed. Sponsored by The First Affiliated Hospital of Guangzhou Medical University, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2022 — Apr 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jun 2022 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jun 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The First Affiliated Hospital of Guangzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .